TSXV - Delayed Quote CAD

Theralase Technologies Inc. (TLT.V)

Compare
0.2650
-0.0100
(-3.64%)
At close: January 15 at 3:58:50 PM EST
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
920.6210
1,070.3070
1,138.5690
780.6410
929.1220
Cost of Revenue
469.5500
508.1730
510.3950
470.6980
659.4420
Gross Profit
451.0710
562.1340
628.1740
309.9430
269.6800
Operating Expense
4,882.4920
5,156.4000
5,859.7180
4,851.4860
5,966.3860
Operating Income
-4,431.4210
-4,594.2660
-5,231.5440
-4,541.5430
-5,696.7060
Net Non Operating Interest Income Expense
31.3090
19.4050
9.4120
17.3200
94.0060
Other Income Expense
-7.0420
3.9810
-13.1700
113.1620
4.1600
Pretax Income
-4,407.1540
-4,570.8800
-5,235.3020
-4,411.0610
-5,598.5400
Net Income Common Stockholders
-4,407.1530
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Diluted NI Available to Com Stockholders
-4,407.1530
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Basic EPS
-0.02
-0.02
-0.03
-0.02
-0.03
Diluted EPS
-0.02
-0.02
-0.03
-0.02
-0.03
Basic Average Shares
232,564.6000
219,968.3790
207,924.3130
204,275.8750
204,275.8750
Diluted Average Shares
232,564.6000
219,968.3790
207,924.3130
204,275.8750
204,275.8750
Rent Expense Supplemental
41.2140
41.2160
47.0970
39.5490
39.9670
Total Expenses
5,352.0420
5,664.5730
6,370.1130
5,322.1840
6,625.8280
Net Income from Continuing & Discontinued Operation
-4,407.1530
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Normalized Income
-4,400.1110
-4,574.8600
-5,222.1320
-4,524.2230
-5,602.7000
Interest Income
58.6340
49.8110
30.6610
22.6620
103.6860
Interest Expense
27.3250
30.4060
21.2490
5.3420
9.6800
Net Interest Income
31.3090
19.4050
9.4120
17.3200
94.0060
EBIT
-4,379.8290
-4,540.4740
-5,214.0530
-4,405.7190
-5,588.8600
EBITDA
-4,100.9730
-4,254.3500
-4,900.8220
-4,129.5690
-5,316.5810
Reconciled Cost of Revenue
235.0720
269.3110
246.0220
271.7060
482.7780
Reconciled Depreciation
278.8560
286.1240
313.2310
276.1500
272.2790
Net Income from Continuing Operation Net Minority Interest
-4,407.1530
-4,570.8790
-5,235.3020
-4,411.0610
-5,598.5400
Total Unusual Items Excluding Goodwill
-7.0420
3.9810
-13.1700
113.1620
4.1600
Total Unusual Items
-7.0420
3.9810
-13.1700
113.1620
4.1600
Normalized EBITDA
-4,093.9310
-4,258.3310
-4,887.6520
-4,242.7310
-5,320.7410
12/31/2020 - 2/13/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VPT.V Ventripoint Diagnostics Ltd.
0.0950
-5.00%
 
THRM.V Therma Bright Inc.
0.0400
-11.11%
 
BLO.CN Cannabix Technologies Inc.
0.3800
-8.43%
 
BTCY Biotricity, Inc.
0.3670
+8.87%
 
QIPT.TO Quipt Home Medical Corp.
4.1700
-5.44%
 
TIVC Tivic Health Systems, Inc.
0.2665
+0.64%
 
VTAK Catheter Precision, Inc.
0.4460
-5.67%
 
NVRO Nevro Corp.
4.2400
+14.59%
 
BDMD Baird Medical Investment Holdings Limited
6.62
-14.36%
 
RXST RxSight, Inc.
31.32
+4.12%